The no-scalpel vasectomy. One solution to this challenge is to identify molecules that can pass through the barrier.
Male hormonal contraception aims to bring a suppression of spermatogenesis using hormonal supplementation. The procedure is minimally invasive, so most men do not experience significant pain. In Asia, and Latin America and the Caribbean — regions with relatively high contraceptive prevalence — the levels of unmet need are However, sperm rebound occurred in 6 men during efficacy phase.
Other trained health workers, for example community health workers, also provide counselling and some family planning methods, for example pills and condoms. Transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
However, many studies had their own limitations. Also, there was a delay in full contraceptive action by months. Cases of human infertility are associated with the absence of P34H an epididymal sperm antigen.
Miglustat has no apparent effect on spermatogenesis in normal men. This inequity is fuelled by both a growing population, and a shortage of family planning services.